Summary

The global iPSC Cell Therapies market size is predicted to grow from US$ 10180 million in 2025 to US$ 21970 million in 2032; it is expected to grow at a CAGR of 11.8% from 2026 to 2032.
Induced pluripotent stem cell (iPSC) cell therapy is a cutting-edge regenerative medicine technology that uses somatic cells to be converted into pluripotent stem cells through genetic reprogramming technology, and then differentiate into specific types of cells for the treatment of various diseases. This technology allows scientists to generate corresponding cells from the patient's own cells, reducing the risk of immune rejection.
United States market for iPSC Cell Therapies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for iPSC Cell Therapies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for iPSC Cell Therapies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key iPSC Cell Therapies players cover Bayer(BlueRock Therapeutics), Notch Therapeutics, Evotec Group, Pluristyx, Inc, Cellino, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “iPSC Cell Therapies Industry Forecast” looks at past sales and reviews total world iPSC Cell Therapies sales in 2025, providing a comprehensive analysis by region and market sector of projected iPSC Cell Therapies sales for 2026 through 2032. With iPSC Cell Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC Cell Therapies industry.
This Insight Report provides a comprehensive analysis of the global iPSC Cell Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on iPSC Cell Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global iPSC Cell Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC Cell Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC Cell Therapies.
This report presents a comprehensive overview, market shares, and growth opportunities of iPSC Cell Therapies market by product type, application, key players and key regions and countries.
Segmentation by Type:
Preclinical/Research Stage
Clinical Stage
Commercial Stage
Segmentation by Application:
Neurodegenerative Diseases
Cardiovascular Diseases
Diabetes
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer(BlueRock Therapeutics)
Notch Therapeutics
Evotec Group
Pluristyx, Inc
Cellino
Fate Therapeutics
Allogene Therapeutics, Inc.
Takeda Pharmaceutical Company Limited
Century Therapeutics
Resolution Therapeutics
Kenai
Garuda Therapeutics
Hebecell
Allele Biotechnology and Pharmaceuticals
Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us
ElevateBio
iCamumo
BeiGene, Ltd
LumiSTAR Biotechnology
Neukio Biotherapeutics
Help Therapeutics
Hopstem Biotechnology Inc.
Nuwacell Biotechnologies Co., Ltd.
ihan Biotech
iRegene
Allife Medicine
CellOrigin
XellSmart bio
ThinkingBioMed
Cell Inspire Bio
Hema Cell
Yuesai BIO
Cytovia

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global iPSC Cell Therapies Market Size (2021-2032)
2.1.2 iPSC Cell Therapies Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for iPSC Cell Therapies by Country/Region (2021, 2025 & 2032)
2.2 iPSC Cell Therapies Segment by Type
2.2.1 Preclinical/Research Stage
2.2.2 Clinical Stage
2.2.3 Commercial Stage
2.2.4 iPSC Cell Therapies Market Size by Type
2.2.4.1 iPSC Cell Therapies Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global iPSC Cell Therapies Market Size Market Share by Type (2021-2026)
2.3 iPSC Cell Therapies Segment by Application
2.3.1 Neurodegenerative Diseases
2.3.2 Cardiovascular Diseases
2.3.3 Diabetes
2.3.4 Other
2.3.5 iPSC Cell Therapies Market Size by Application
2.3.5.1 iPSC Cell Therapies Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global iPSC Cell Therapies Market Size Market Share by Application (2021-2026)
3 iPSC Cell Therapies Market Size by Player
3.1 iPSC Cell Therapies Market Size Market Share by Player
3.1.1 Global iPSC Cell Therapies Revenue by Player (2021-2026)
3.1.2 Global iPSC Cell Therapies Revenue Market Share by Player (2021-2026)
3.2 Global iPSC Cell Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 iPSC Cell Therapies by Region
4.1 iPSC Cell Therapies Market Size by Region (2021-2026)
4.2 Global iPSC Cell Therapies Annual Revenue by Country/Region (2021-2026)
4.3 Americas iPSC Cell Therapies Market Size Growth (2021-2026)
4.4 APAC iPSC Cell Therapies Market Size Growth (2021-2026)
4.5 Europe iPSC Cell Therapies Market Size Growth (2021-2026)
4.6 Middle East & Africa iPSC Cell Therapies Market Size Growth (2021-2026)
5 Americas
5.1 Americas iPSC Cell Therapies Market Size by Country (2021-2026)
5.2 Americas iPSC Cell Therapies Market Size by Type (2021-2026)
5.3 Americas iPSC Cell Therapies Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC iPSC Cell Therapies Market Size by Region (2021-2026)
6.2 APAC iPSC Cell Therapies Market Size by Type (2021-2026)
6.3 APAC iPSC Cell Therapies Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe iPSC Cell Therapies Market Size by Country (2021-2026)
7.2 Europe iPSC Cell Therapies Market Size by Type (2021-2026)
7.3 Europe iPSC Cell Therapies Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa iPSC Cell Therapies by Region (2021-2026)
8.2 Middle East & Africa iPSC Cell Therapies Market Size by Type (2021-2026)
8.3 Middle East & Africa iPSC Cell Therapies Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global iPSC Cell Therapies Market Forecast
10.1 Global iPSC Cell Therapies Forecast by Region (2027-2032)
10.1.1 Global iPSC Cell Therapies Forecast by Region (2027-2032)
10.1.2 Americas iPSC Cell Therapies Forecast
10.1.3 APAC iPSC Cell Therapies Forecast
10.1.4 Europe iPSC Cell Therapies Forecast
10.1.5 Middle East & Africa iPSC Cell Therapies Forecast
10.2 Americas iPSC Cell Therapies Forecast by Country (2027-2032)
10.2.1 United States Market iPSC Cell Therapies Forecast
10.2.2 Canada Market iPSC Cell Therapies Forecast
10.2.3 Mexico Market iPSC Cell Therapies Forecast
10.2.4 Brazil Market iPSC Cell Therapies Forecast
10.3 APAC iPSC Cell Therapies Forecast by Region (2027-2032)
10.3.1 China iPSC Cell Therapies Market Forecast
10.3.2 Japan Market iPSC Cell Therapies Forecast
10.3.3 Korea Market iPSC Cell Therapies Forecast
10.3.4 Southeast Asia Market iPSC Cell Therapies Forecast
10.3.5 India Market iPSC Cell Therapies Forecast
10.3.6 Australia Market iPSC Cell Therapies Forecast
10.4 Europe iPSC Cell Therapies Forecast by Country (2027-2032)
10.4.1 Germany Market iPSC Cell Therapies Forecast
10.4.2 France Market iPSC Cell Therapies Forecast
10.4.3 UK Market iPSC Cell Therapies Forecast
10.4.4 Italy Market iPSC Cell Therapies Forecast
10.4.5 Russia Market iPSC Cell Therapies Forecast
10.5 Middle East & Africa iPSC Cell Therapies Forecast by Region (2027-2032)
10.5.1 Egypt Market iPSC Cell Therapies Forecast
10.5.2 South Africa Market iPSC Cell Therapies Forecast
10.5.3 Israel Market iPSC Cell Therapies Forecast
10.5.4 Turkey Market iPSC Cell Therapies Forecast
10.6 Global iPSC Cell Therapies Forecast by Type (2027-2032)
10.7 Global iPSC Cell Therapies Forecast by Application (2027-2032)
10.7.1 GCC Countries Market iPSC Cell Therapies Forecast
11 Key Players Analysis
11.1 Bayer(BlueRock Therapeutics)
11.1.1 Bayer(BlueRock Therapeutics) Company Information
11.1.2 Bayer(BlueRock Therapeutics) iPSC Cell Therapies Product Offered
11.1.3 Bayer(BlueRock Therapeutics) iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Bayer(BlueRock Therapeutics) Main Business Overview
11.1.5 Bayer(BlueRock Therapeutics) Latest Developments
11.2 Notch Therapeutics
11.2.1 Notch Therapeutics Company Information
11.2.2 Notch Therapeutics iPSC Cell Therapies Product Offered
11.2.3 Notch Therapeutics iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Notch Therapeutics Main Business Overview
11.2.5 Notch Therapeutics Latest Developments
11.3 Evotec Group
11.3.1 Evotec Group Company Information
11.3.2 Evotec Group iPSC Cell Therapies Product Offered
11.3.3 Evotec Group iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Evotec Group Main Business Overview
11.3.5 Evotec Group Latest Developments
11.4 Pluristyx, Inc
11.4.1 Pluristyx, Inc Company Information
11.4.2 Pluristyx, Inc iPSC Cell Therapies Product Offered
11.4.3 Pluristyx, Inc iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Pluristyx, Inc Main Business Overview
11.4.5 Pluristyx, Inc Latest Developments
11.5 Cellino
11.5.1 Cellino Company Information
11.5.2 Cellino iPSC Cell Therapies Product Offered
11.5.3 Cellino iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Cellino Main Business Overview
11.5.5 Cellino Latest Developments
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Information
11.6.2 Fate Therapeutics iPSC Cell Therapies Product Offered
11.6.3 Fate Therapeutics iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fate Therapeutics Main Business Overview
11.6.5 Fate Therapeutics Latest Developments
11.7 Allogene Therapeutics, Inc.
11.7.1 Allogene Therapeutics, Inc. Company Information
11.7.2 Allogene Therapeutics, Inc. iPSC Cell Therapies Product Offered
11.7.3 Allogene Therapeutics, Inc. iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Allogene Therapeutics, Inc. Main Business Overview
11.7.5 Allogene Therapeutics, Inc. Latest Developments
11.8 Takeda Pharmaceutical Company Limited
11.8.1 Takeda Pharmaceutical Company Limited Company Information
11.8.2 Takeda Pharmaceutical Company Limited iPSC Cell Therapies Product Offered
11.8.3 Takeda Pharmaceutical Company Limited iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Takeda Pharmaceutical Company Limited Main Business Overview
11.8.5 Takeda Pharmaceutical Company Limited Latest Developments
11.9 Century Therapeutics
11.9.1 Century Therapeutics Company Information
11.9.2 Century Therapeutics iPSC Cell Therapies Product Offered
11.9.3 Century Therapeutics iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Century Therapeutics Main Business Overview
11.9.5 Century Therapeutics Latest Developments
11.10 Resolution Therapeutics
11.10.1 Resolution Therapeutics Company Information
11.10.2 Resolution Therapeutics iPSC Cell Therapies Product Offered
11.10.3 Resolution Therapeutics iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Resolution Therapeutics Main Business Overview
11.10.5 Resolution Therapeutics Latest Developments
11.11 Kenai
11.11.1 Kenai Company Information
11.11.2 Kenai iPSC Cell Therapies Product Offered
11.11.3 Kenai iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Kenai Main Business Overview
11.11.5 Kenai Latest Developments
11.12 Garuda Therapeutics
11.12.1 Garuda Therapeutics Company Information
11.12.2 Garuda Therapeutics iPSC Cell Therapies Product Offered
11.12.3 Garuda Therapeutics iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Garuda Therapeutics Main Business Overview
11.12.5 Garuda Therapeutics Latest Developments
11.13 Hebecell
11.13.1 Hebecell Company Information
11.13.2 Hebecell iPSC Cell Therapies Product Offered
11.13.3 Hebecell iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Hebecell Main Business Overview
11.13.5 Hebecell Latest Developments
11.14 Allele Biotechnology and Pharmaceuticals
11.14.1 Allele Biotechnology and Pharmaceuticals Company Information
11.14.2 Allele Biotechnology and Pharmaceuticals iPSC Cell Therapies Product Offered
11.14.3 Allele Biotechnology and Pharmaceuticals iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Allele Biotechnology and Pharmaceuticals Main Business Overview
11.14.5 Allele Biotechnology and Pharmaceuticals Latest Developments
11.15 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us
11.15.1 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Company Information
11.15.2 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us iPSC Cell Therapies Product Offered
11.15.3 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Main Business Overview
11.15.5 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Latest Developments
11.16 ElevateBio
11.16.1 ElevateBio Company Information
11.16.2 ElevateBio iPSC Cell Therapies Product Offered
11.16.3 ElevateBio iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 ElevateBio Main Business Overview
11.16.5 ElevateBio Latest Developments
11.17 iCamumo
11.17.1 iCamumo Company Information
11.17.2 iCamumo iPSC Cell Therapies Product Offered
11.17.3 iCamumo iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 iCamumo Main Business Overview
11.17.5 iCamumo Latest Developments
11.18 BeiGene, Ltd
11.18.1 BeiGene, Ltd Company Information
11.18.2 BeiGene, Ltd iPSC Cell Therapies Product Offered
11.18.3 BeiGene, Ltd iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 BeiGene, Ltd Main Business Overview
11.18.5 BeiGene, Ltd Latest Developments
11.19 LumiSTAR Biotechnology
11.19.1 LumiSTAR Biotechnology Company Information
11.19.2 LumiSTAR Biotechnology iPSC Cell Therapies Product Offered
11.19.3 LumiSTAR Biotechnology iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 LumiSTAR Biotechnology Main Business Overview
11.19.5 LumiSTAR Biotechnology Latest Developments
11.20 Neukio Biotherapeutics
11.20.1 Neukio Biotherapeutics Company Information
11.20.2 Neukio Biotherapeutics iPSC Cell Therapies Product Offered
11.20.3 Neukio Biotherapeutics iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Neukio Biotherapeutics Main Business Overview
11.20.5 Neukio Biotherapeutics Latest Developments
11.21 Help Therapeutics
11.21.1 Help Therapeutics Company Information
11.21.2 Help Therapeutics iPSC Cell Therapies Product Offered
11.21.3 Help Therapeutics iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Help Therapeutics Main Business Overview
11.21.5 Help Therapeutics Latest Developments
11.22 Hopstem Biotechnology Inc.
11.22.1 Hopstem Biotechnology Inc. Company Information
11.22.2 Hopstem Biotechnology Inc. iPSC Cell Therapies Product Offered
11.22.3 Hopstem Biotechnology Inc. iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Hopstem Biotechnology Inc. Main Business Overview
11.22.5 Hopstem Biotechnology Inc. Latest Developments
11.23 Nuwacell Biotechnologies Co., Ltd.
11.23.1 Nuwacell Biotechnologies Co., Ltd. Company Information
11.23.2 Nuwacell Biotechnologies Co., Ltd. iPSC Cell Therapies Product Offered
11.23.3 Nuwacell Biotechnologies Co., Ltd. iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Nuwacell Biotechnologies Co., Ltd. Main Business Overview
11.23.5 Nuwacell Biotechnologies Co., Ltd. Latest Developments
11.24 ihan Biotech
11.24.1 ihan Biotech Company Information
11.24.2 ihan Biotech iPSC Cell Therapies Product Offered
11.24.3 ihan Biotech iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 ihan Biotech Main Business Overview
11.24.5 ihan Biotech Latest Developments
11.25 iRegene
11.25.1 iRegene Company Information
11.25.2 iRegene iPSC Cell Therapies Product Offered
11.25.3 iRegene iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 iRegene Main Business Overview
11.25.5 iRegene Latest Developments
11.26 Allife Medicine
11.26.1 Allife Medicine Company Information
11.26.2 Allife Medicine iPSC Cell Therapies Product Offered
11.26.3 Allife Medicine iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Allife Medicine Main Business Overview
11.26.5 Allife Medicine Latest Developments
11.27 CellOrigin
11.27.1 CellOrigin Company Information
11.27.2 CellOrigin iPSC Cell Therapies Product Offered
11.27.3 CellOrigin iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 CellOrigin Main Business Overview
11.27.5 CellOrigin Latest Developments
11.28 XellSmart bio
11.28.1 XellSmart bio Company Information
11.28.2 XellSmart bio iPSC Cell Therapies Product Offered
11.28.3 XellSmart bio iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 XellSmart bio Main Business Overview
11.28.5 XellSmart bio Latest Developments
11.29 ThinkingBioMed
11.29.1 ThinkingBioMed Company Information
11.29.2 ThinkingBioMed iPSC Cell Therapies Product Offered
11.29.3 ThinkingBioMed iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 ThinkingBioMed Main Business Overview
11.29.5 ThinkingBioMed Latest Developments
11.30 Cell Inspire Bio
11.30.1 Cell Inspire Bio Company Information
11.30.2 Cell Inspire Bio iPSC Cell Therapies Product Offered
11.30.3 Cell Inspire Bio iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Cell Inspire Bio Main Business Overview
11.30.5 Cell Inspire Bio Latest Developments
11.31 Hema Cell
11.31.1 Hema Cell Company Information
11.31.2 Hema Cell iPSC Cell Therapies Product Offered
11.31.3 Hema Cell iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 Hema Cell Main Business Overview
11.31.5 Hema Cell Latest Developments
11.32 Yuesai BIO
11.32.1 Yuesai BIO Company Information
11.32.2 Yuesai BIO iPSC Cell Therapies Product Offered
11.32.3 Yuesai BIO iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 Yuesai BIO Main Business Overview
11.32.5 Yuesai BIO Latest Developments
11.33 Cytovia
11.33.1 Cytovia Company Information
11.33.2 Cytovia iPSC Cell Therapies Product Offered
11.33.3 Cytovia iPSC Cell Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 Cytovia Main Business Overview
11.33.5 Cytovia Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. iPSC Cell Therapies Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. iPSC Cell Therapies Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Preclinical/Research Stage
Table 4. Major Players of Clinical Stage
Table 5. Major Players of Commercial Stage
Table 6. iPSC Cell Therapies Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global iPSC Cell Therapies Market Size by Type (2021-2026) & ($ millions)
Table 8. Global iPSC Cell Therapies Market Size Market Share by Type (2021-2026)
Table 9. iPSC Cell Therapies Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global iPSC Cell Therapies Market Size by Application (2021-2026) & ($ millions)
Table 11. Global iPSC Cell Therapies Market Size Market Share by Application (2021-2026)
Table 12. Global iPSC Cell Therapies Revenue by Player (2021-2026) & ($ millions)
Table 13. Global iPSC Cell Therapies Revenue Market Share by Player (2021-2026)
Table 14. iPSC Cell Therapies Key Players Head office and Products Offered
Table 15. iPSC Cell Therapies Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global iPSC Cell Therapies Market Size by Region (2021-2026) & ($ millions)
Table 19. Global iPSC Cell Therapies Market Size Market Share by Region (2021-2026)
Table 20. Global iPSC Cell Therapies Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global iPSC Cell Therapies Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas iPSC Cell Therapies Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas iPSC Cell Therapies Market Size Market Share by Country (2021-2026)
Table 24. Americas iPSC Cell Therapies Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas iPSC Cell Therapies Market Size Market Share by Type (2021-2026)
Table 26. Americas iPSC Cell Therapies Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas iPSC Cell Therapies Market Size Market Share by Application (2021-2026)
Table 28. APAC iPSC Cell Therapies Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC iPSC Cell Therapies Market Size Market Share by Region (2021-2026)
Table 30. APAC iPSC Cell Therapies Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC iPSC Cell Therapies Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe iPSC Cell Therapies Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe iPSC Cell Therapies Market Size Market Share by Country (2021-2026)
Table 34. Europe iPSC Cell Therapies Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe iPSC Cell Therapies Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa iPSC Cell Therapies Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa iPSC Cell Therapies Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa iPSC Cell Therapies Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of iPSC Cell Therapies
Table 40. Key Market Challenges & Risks of iPSC Cell Therapies
Table 41. Key Industry Trends of iPSC Cell Therapies
Table 42. Global iPSC Cell Therapies Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global iPSC Cell Therapies Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global iPSC Cell Therapies Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global iPSC Cell Therapies Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Bayer(BlueRock Therapeutics) Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 47. Bayer(BlueRock Therapeutics) iPSC Cell Therapies Product Offered
Table 48. Bayer(BlueRock Therapeutics) iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Bayer(BlueRock Therapeutics) Main Business
Table 50. Bayer(BlueRock Therapeutics) Latest Developments
Table 51. Notch Therapeutics Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 52. Notch Therapeutics iPSC Cell Therapies Product Offered
Table 53. Notch Therapeutics iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Notch Therapeutics Main Business
Table 55. Notch Therapeutics Latest Developments
Table 56. Evotec Group Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 57. Evotec Group iPSC Cell Therapies Product Offered
Table 58. Evotec Group iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Evotec Group Main Business
Table 60. Evotec Group Latest Developments
Table 61. Pluristyx, Inc Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 62. Pluristyx, Inc iPSC Cell Therapies Product Offered
Table 63. Pluristyx, Inc iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Pluristyx, Inc Main Business
Table 65. Pluristyx, Inc Latest Developments
Table 66. Cellino Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 67. Cellino iPSC Cell Therapies Product Offered
Table 68. Cellino iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Cellino Main Business
Table 70. Cellino Latest Developments
Table 71. Fate Therapeutics Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 72. Fate Therapeutics iPSC Cell Therapies Product Offered
Table 73. Fate Therapeutics iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Fate Therapeutics Main Business
Table 75. Fate Therapeutics Latest Developments
Table 76. Allogene Therapeutics, Inc. Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 77. Allogene Therapeutics, Inc. iPSC Cell Therapies Product Offered
Table 78. Allogene Therapeutics, Inc. iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Allogene Therapeutics, Inc. Main Business
Table 80. Allogene Therapeutics, Inc. Latest Developments
Table 81. Takeda Pharmaceutical Company Limited Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 82. Takeda Pharmaceutical Company Limited iPSC Cell Therapies Product Offered
Table 83. Takeda Pharmaceutical Company Limited iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Takeda Pharmaceutical Company Limited Main Business
Table 85. Takeda Pharmaceutical Company Limited Latest Developments
Table 86. Century Therapeutics Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 87. Century Therapeutics iPSC Cell Therapies Product Offered
Table 88. Century Therapeutics iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Century Therapeutics Main Business
Table 90. Century Therapeutics Latest Developments
Table 91. Resolution Therapeutics Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 92. Resolution Therapeutics iPSC Cell Therapies Product Offered
Table 93. Resolution Therapeutics iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Resolution Therapeutics Main Business
Table 95. Resolution Therapeutics Latest Developments
Table 96. Kenai Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 97. Kenai iPSC Cell Therapies Product Offered
Table 98. Kenai iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Kenai Main Business
Table 100. Kenai Latest Developments
Table 101. Garuda Therapeutics Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 102. Garuda Therapeutics iPSC Cell Therapies Product Offered
Table 103. Garuda Therapeutics iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Garuda Therapeutics Main Business
Table 105. Garuda Therapeutics Latest Developments
Table 106. Hebecell Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 107. Hebecell iPSC Cell Therapies Product Offered
Table 108. Hebecell iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Hebecell Main Business
Table 110. Hebecell Latest Developments
Table 111. Allele Biotechnology and Pharmaceuticals Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 112. Allele Biotechnology and Pharmaceuticals iPSC Cell Therapies Product Offered
Table 113. Allele Biotechnology and Pharmaceuticals iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Allele Biotechnology and Pharmaceuticals Main Business
Table 115. Allele Biotechnology and Pharmaceuticals Latest Developments
Table 116. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 117. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us iPSC Cell Therapies Product Offered
Table 118. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Main Business
Table 120. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Latest Developments
Table 121. ElevateBio Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 122. ElevateBio iPSC Cell Therapies Product Offered
Table 123. ElevateBio iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. ElevateBio Main Business
Table 125. ElevateBio Latest Developments
Table 126. iCamumo Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 127. iCamumo iPSC Cell Therapies Product Offered
Table 128. iCamumo iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. iCamumo Main Business
Table 130. iCamumo Latest Developments
Table 131. BeiGene, Ltd Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 132. BeiGene, Ltd iPSC Cell Therapies Product Offered
Table 133. BeiGene, Ltd iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. BeiGene, Ltd Main Business
Table 135. BeiGene, Ltd Latest Developments
Table 136. LumiSTAR Biotechnology Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 137. LumiSTAR Biotechnology iPSC Cell Therapies Product Offered
Table 138. LumiSTAR Biotechnology iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. LumiSTAR Biotechnology Main Business
Table 140. LumiSTAR Biotechnology Latest Developments
Table 141. Neukio Biotherapeutics Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 142. Neukio Biotherapeutics iPSC Cell Therapies Product Offered
Table 143. Neukio Biotherapeutics iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Neukio Biotherapeutics Main Business
Table 145. Neukio Biotherapeutics Latest Developments
Table 146. Help Therapeutics Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 147. Help Therapeutics iPSC Cell Therapies Product Offered
Table 148. Help Therapeutics iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Help Therapeutics Main Business
Table 150. Help Therapeutics Latest Developments
Table 151. Hopstem Biotechnology Inc. Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 152. Hopstem Biotechnology Inc. iPSC Cell Therapies Product Offered
Table 153. Hopstem Biotechnology Inc. iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Hopstem Biotechnology Inc. Main Business
Table 155. Hopstem Biotechnology Inc. Latest Developments
Table 156. Nuwacell Biotechnologies Co., Ltd. Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 157. Nuwacell Biotechnologies Co., Ltd. iPSC Cell Therapies Product Offered
Table 158. Nuwacell Biotechnologies Co., Ltd. iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Nuwacell Biotechnologies Co., Ltd. Main Business
Table 160. Nuwacell Biotechnologies Co., Ltd. Latest Developments
Table 161. ihan Biotech Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 162. ihan Biotech iPSC Cell Therapies Product Offered
Table 163. ihan Biotech iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. ihan Biotech Main Business
Table 165. ihan Biotech Latest Developments
Table 166. iRegene Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 167. iRegene iPSC Cell Therapies Product Offered
Table 168. iRegene iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. iRegene Main Business
Table 170. iRegene Latest Developments
Table 171. Allife Medicine Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 172. Allife Medicine iPSC Cell Therapies Product Offered
Table 173. Allife Medicine iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 174. Allife Medicine Main Business
Table 175. Allife Medicine Latest Developments
Table 176. CellOrigin Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 177. CellOrigin iPSC Cell Therapies Product Offered
Table 178. CellOrigin iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 179. CellOrigin Main Business
Table 180. CellOrigin Latest Developments
Table 181. XellSmart bio Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 182. XellSmart bio iPSC Cell Therapies Product Offered
Table 183. XellSmart bio iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 184. XellSmart bio Main Business
Table 185. XellSmart bio Latest Developments
Table 186. ThinkingBioMed Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 187. ThinkingBioMed iPSC Cell Therapies Product Offered
Table 188. ThinkingBioMed iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 189. ThinkingBioMed Main Business
Table 190. ThinkingBioMed Latest Developments
Table 191. Cell Inspire Bio Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 192. Cell Inspire Bio iPSC Cell Therapies Product Offered
Table 193. Cell Inspire Bio iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 194. Cell Inspire Bio Main Business
Table 195. Cell Inspire Bio Latest Developments
Table 196. Hema Cell Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 197. Hema Cell iPSC Cell Therapies Product Offered
Table 198. Hema Cell iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 199. Hema Cell Main Business
Table 200. Hema Cell Latest Developments
Table 201. Yuesai BIO Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 202. Yuesai BIO iPSC Cell Therapies Product Offered
Table 203. Yuesai BIO iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 204. Yuesai BIO Main Business
Table 205. Yuesai BIO Latest Developments
Table 206. Cytovia Details, Company Type, iPSC Cell Therapies Area Served and Its Competitors
Table 207. Cytovia iPSC Cell Therapies Product Offered
Table 208. Cytovia iPSC Cell Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 209. Cytovia Main Business
Table 210. Cytovia Latest Developments


List of Figures
Figure 1. iPSC Cell Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global iPSC Cell Therapies Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. iPSC Cell Therapies Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. iPSC Cell Therapies Sales Market Share by Country/Region (2025)
Figure 8. iPSC Cell Therapies Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global iPSC Cell Therapies Market Size Market Share by Type in 2025
Figure 10. iPSC Cell Therapies in Neurodegenerative Diseases
Figure 11. Global iPSC Cell Therapies Market: Neurodegenerative Diseases (2021-2026) & ($ millions)
Figure 12. iPSC Cell Therapies in Cardiovascular Diseases
Figure 13. Global iPSC Cell Therapies Market: Cardiovascular Diseases (2021-2026) & ($ millions)
Figure 14. iPSC Cell Therapies in Diabetes
Figure 15. Global iPSC Cell Therapies Market: Diabetes (2021-2026) & ($ millions)
Figure 16. iPSC Cell Therapies in Other
Figure 17. Global iPSC Cell Therapies Market: Other (2021-2026) & ($ millions)
Figure 18. Global iPSC Cell Therapies Market Size Market Share by Application in 2025
Figure 19. Global iPSC Cell Therapies Revenue Market Share by Player in 2025
Figure 20. Global iPSC Cell Therapies Market Size Market Share by Region (2021-2026)
Figure 21. Americas iPSC Cell Therapies Market Size 2021-2026 ($ millions)
Figure 22. APAC iPSC Cell Therapies Market Size 2021-2026 ($ millions)
Figure 23. Europe iPSC Cell Therapies Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa iPSC Cell Therapies Market Size 2021-2026 ($ millions)
Figure 25. Americas iPSC Cell Therapies Value Market Share by Country in 2025
Figure 26. United States iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC iPSC Cell Therapies Market Size Market Share by Region in 2025
Figure 31. APAC iPSC Cell Therapies Market Size Market Share by Type (2021-2026)
Figure 32. APAC iPSC Cell Therapies Market Size Market Share by Application (2021-2026)
Figure 33. China iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 37. India iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe iPSC Cell Therapies Market Size Market Share by Country in 2025
Figure 40. Europe iPSC Cell Therapies Market Size Market Share by Type (2021-2026)
Figure 41. Europe iPSC Cell Therapies Market Size Market Share by Application (2021-2026)
Figure 42. Germany iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 43. France iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 44. UK iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa iPSC Cell Therapies Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa iPSC Cell Therapies Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa iPSC Cell Therapies Market Size Market Share by Application (2021-2026)
Figure 50. Egypt iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries iPSC Cell Therapies Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 56. APAC iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 57. Europe iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 59. United States iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 60. Canada iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 61. Mexico iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 62. Brazil iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 63. China iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 64. Japan iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 65. Korea iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 67. India iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 68. Australia iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 69. Germany iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 70. France iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 71. UK iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 72. Italy iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 73. Russia iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 74. Egypt iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 75. South Africa iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 76. Israel iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 77. Turkey iPSC Cell Therapies Market Size 2027-2032 ($ millions)
Figure 78. Global iPSC Cell Therapies Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global iPSC Cell Therapies Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries iPSC Cell Therapies Market Size 2027-2032 ($ millions)